T. Rowe Price Investment Management, Inc. 13D and 13G filings for Avanos Medical, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 09:45 am Purchase |
2024-12-31 | 13G | Avanos Medical, Inc. AVNS |
T. Rowe Price Investment Management, Inc. | 3,011,312 6.600% |
644,267 (+27.22%) |
Filing |
| 2024-11-14 1:28 pm Purchase |
2024-09-30 | 13G | Avanos Medical, Inc. AVNS |
T. Rowe Price Investment Management, Inc. | 2,367,045 5.200% |
2,367,045 (New Position) |
Filing |